Final Four Stocks: Celgene vs. Johnson & Johnson

The Motley Fool's exclusive health-care stock tournament moves closer to crowning a champion.

Dave Williamson
Dave Williamson and Max Macaluso
Apr 6, 2013 at 6:00PM
Health Care

With March Madness in full swing, we decided to stick with what we know here at The Motley Fool, trading our basketball picks in for stock picks. We formed our own bracket filled with the top Big Pharma and Big Biotech stocks in a winner take-all tournament as determined by the collective intelligence of our CAPS community.

This Final Four matchup is a heavyweight bout between Celgene and Johnson & Johnson. Watch and find out what J&J and embattled Rutgers University have in common and whether Celgene's style of play is enough to advance to the championship round.